HOME >> MEDICINE >> NEWS
Glaucoma treatment time and costs increase as disease progresses

Delaying the progression of the eye disease glaucoma from advancing to later stages is associated with lower cost of care, according to a study in the January issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

Glaucoma affects an estimated 2.2 million Americans older than age 40 years, half of whom remain undiagnosed, the authors provide as background information in the article. "The incidence of glaucoma is expected to rise with the growth of the elderly population. Glaucoma costs the U.S. health care system an estimated $2.5 billion annually: $1.9 billion in direct costs and $0.6 billion in indirect costs," the authors write. Glaucoma is an eye disease characterized by damage to the optic nerve and loss of vision, usually the result of high pressure in the eye.

Paul P. Lee, M.D., J.D., from Duke University Medical Center, Durham, N.C., and colleagues analyzed 151 records of patients with primary open-angle or normal-tension glaucoma, glaucoma suspect, or ocular hypertension to determine if use of physician and other services for low vision care and vision rehabilitation, and direct costs of care increased with progression of disease severity.

"Direct ophthalmology-related resource use, including ophthalmology visits, glaucoma surgeries, and medication use, increased as disease severity worsened," the researchers found. "Average direct cost of treatment ranged from $623 per patient per year for glaucoma suspects or patients with early-stage disease to $2,511 per patient per year for patients with end-stage disease. Medication costs composed the largest proportion of total direct cost for all stages of disease." The researchers add that glaucoma is "generally asymptomatic or nonspecific in its symptoms in its earlier phases, resulting in delayed diagnosis and relatively increased medical vigilance throughout the later stages of the disease."


'"/>

Contact: Tracey Koepke
919-660-1301
JAMA and Archives Journals
9-Jan-2006


Page: 1

Related medicine news :

1. Glaucoma patients appear to have increased eye pressure during sleep
2. Spot on treatment for acne
3. New treatment boosts muscle function in myasthenia gravis
4. New treatment effective in counteracting cocaine-induced symptoms
5. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
6. Preventive treatments in elderly people needs rethinking
7. Osteoporosis screening and treatment may be cost-effective for selected older men
8. Quality of treatment guidelines
9. Green tea holds promise as new treatment for inflammatory skin diseases
10. Many heart attack patients still not getting emergency clot-busting treatment
11. Electric fields have potential as a cancer treatment

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Glaucoma treatment time and costs increase disease progresses

(Date:7/1/2015)... ... July 01, 2015 , ... ... new extraction plant for Linablue®, Spirulina-derived natural blue food coloring. Construction of the ... DIC Group’s U.S. Spirulina* production base, began in May 2014. After commissioning, commercial ...
(Date:7/1/2015)... ... July 01, 2015 , ... Renowned rhinoplasty surgeon and ... 2016 Dallas Rhinoplasty Symposium . Set for March 6th - 8th, the 2016 ... participants from the basic training and fundamentals of nasal surgery through the most modern ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... leaders Lora Posey (Manager, National Sales Training and Development) and Chuck Corso (Associate ... (LTEN) Conference in Phoenix, AZ. LTEN brings together learning and development professionals from ...
(Date:7/1/2015)... ... - (PRWEB) July 01, 2015 , ... Lisa Keys, ... virtual 5K on August 15-16th (MSG Keys’ birthday) in memory of her late husband ... decorated soldier and recipient of the Bronze Star Medal, died during a Special Forces ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... author Lisa Stolzenberg, a Professor in FIU’s School of International and Public Affairs. ... 17 years who participated in the National Survey on Drug Use and Health, ...
Breaking Medicine News(10 mins):Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 2Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 3Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2
(Date:7/1/2015)... it is expanding its Baltimore -based clinical studies network and is recruiting ... patient populations.  Photo - http://photos.prnewswire.com/prnh/20150630/227303 ... ... ... "Continental hosts clinical studies for physicians across all ...
(Date:7/1/2015)... 2015  BioPharmX Corporation (NYSE MKT: BPMX) today announced ... of 3,636,364 shares of its common stock at a ... has granted the underwriters a 30-day option to purchase ... the public offering price. In addition, Korea ... has agreed to purchase 1,081,081 shares of common stock ...
(Date:7/1/2015)... ZURICH , July 1, 2015 ... reorganise its Executive Board. Mr. Gert Weber ... Medico Invest AG as Chief Executive Officer (CEO) ... starting July 1 st , 2015. Mr. Weber brings ... and technological industries and has filled various executive management ...
Breaking Medicine Technology:Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 3Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 4BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3Haselmeier Group Announces the Extension and Reorganization of its Executive Board 2
Cached News: